Work

Study of the effectiveness of avonex in multiple sclerosis (1-year treatment)

Year: 2017

Type: article

Abstract: In the paper, the results of 1-year treatment with avonex, a newimmunomodulator from the group of interferons b, in 34patients with relapsing remitting multiple sclerosis have beenreported. In the treated patients it was shown significantdecrease of the activity of the pathological process, which wasevidenced by reduction of the severity of exacerbations and therelapse rate. The decrease of disability of patients with multiplesclerosis (by EDSS score) was revealed. In general, one cannotice good tolerability of avonex.

Source: DOAJ (DOAJ: Directory of Open Access Journals)

DOI: 10.17816/psaic366

Authors: I. A. Zavalishin, A. V. Peresedova, N. I. Stoida, L. Sh. Askarova, M. N. Zakharova, L. S. Adarcheva, A. S. Niyazbekova, O. V. Trifonova, O. Yu. Rebrova, D. D. Eliseeva

Institution: Research Center of Neurology

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3217005476

FWCI:

Cites:

Cited by:

Related to: 10